Literature DB >> 8591121

Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn.

J T Daugirdas1.   

Abstract

Although computer solution of the differential equations used in urea kinetic modeling has its advantages, simplified formulas that are actually approximate algebraic solutions to the same equations in the clinically useful range are also useful. The Kt/V can be resolved from the predialysis to postdialysis urea nitrogen ratio (R), the weight loss (UF), session length in hours (t), and anthropometric or modeled volume (V) using the equation: KtV = In (R - 0.008 x t) + (4 - 3.5 x R) x 0.55 UF/V. The equilibrated Kt/V (eKTV) can be estimated from the single-pool arterial Kt/V (spaKTV) or the single-pool venous Kt/V (spmvKTV) using a rate equation based on the regional blood flow model of urea kinetics: eKTV = spaKTV - (0.60)(spaKTV)/t + 0.03 = spmvKTV - (0.46) (spmvKTV)/t + 0.02. The normalized protein catabolic rate (PCRn) can be determined from either the single-pool or equilibrated Kt/V based on the predialysis urea nitrogen level (C0) and the Kt/V (KTV) using the generalized equation: PCRn = C0/(a + bKTV + c/ + KTV) + 0.168, where the constants a, b, and c vary depending on the dialysis schedule and the time of the week that the predialysis blood specimen has been drawn. Such equations can be used either for retrospective surveys, or for quality assurance purposes, as well as for bedside guidance in an individual patient. The actual modeled urea distribution volume can also be easily computed if some effort is made to estimate the dialyzer urea clearance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591121     DOI: 10.1016/s1073-4449(12)80028-8

Source DB:  PubMed          Journal:  Adv Ren Replace Ther        ISSN: 1073-4449


  49 in total

1.  Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status.

Authors:  Salwa Ibrahim; Sharaf el-Din; Ibrahim Bazzal
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

2.  Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD.

Authors:  Francesco Locatelli; Paolo Altieri; Simeone Andrulli; Piergiorgio Bolasco; Giovanna Sau; Luciano A Pedrini; Carlo Basile; Salvatore David; Mariano Feriani; Giovanni Montagna; Biagio Raffaele Di Iorio; Bruno Memoli; Raffaella Cravero; Giovanni Battaglia; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

3.  Short stature and growth hormone use in pediatric hemodialysis patients.

Authors:  Gregory Gorman; Barbara Fivush; Diane Frankenfield; Bradley Warady; Sandra Watkins; Andrew Brem; Alicia Neu
Journal:  Pediatr Nephrol       Date:  2005-08-18       Impact factor: 3.714

Review 4.  Assessment of nutritional status in children with chronic kidney disease and on dialysis.

Authors:  Antonio Mastrangelo; Fabio Paglialonga; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

5.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

6.  Modulation of the immune response to HBV vaccination by hemodialysis membranes.

Authors:  Fatih Dede; Ayla Yıldız; Deniz Aylı; Nujen Colak; Ali Rıza Odabaş; Hadim Akoğlu; Erdal Eskioğlu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2009-07-19       Impact factor: 2.370

Review 7.  Aldosterone is associated with left ventricular hypertrophy in hemodialysis patients.

Authors:  Greicy Mara Mengue Feniman De Stefano; Silméia Garcia Zanati-Basan; Laercio Martins De Stefano; Viviana Rugolo Oliveira E Silva; Patrícia Santi Xavier; Pasqual Barretti; Roberto Jorge da Silva Franco; Jacqueline Costa Teixeira Caramori; Luis Cuadrado Martin
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-04-27

8.  Dialysate-side urea kinetics. Neural network predicts dialysis dose during dialysis.

Authors:  E A Fernández; R Valtuille; P Willshaw; C A Perazzo
Journal:  Med Biol Eng Comput       Date:  2003-07       Impact factor: 2.602

9.  Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.

Authors:  Bradley L Urquhart; David J Freeman; Murray J Cutler; Rahul Mainra; J David Spence; Andrew A House
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 8.237

10.  Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study.

Authors:  Rafael Pérez-García; Alejandro Martín-Malo; Joan Fort; Xavier Cuevas; Fina Lladós; Javier Lozano; Fernando García
Journal:  Nephrol Dial Transplant       Date:  2008-11-21       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.